These findings position henagliflozin at the intersection of diabetes care and longevity science. They are raising both optimism and debate over whether existing medications might also serve as anti-aging therapies.
Freepik Company S.L. – www.freepik.com
Henagliflozin, a diabetes treatment approved in China, may do more than just control blood sugar—it may actually slow biological aging. Long prescribed to patients with type 2 diabetes to manage glucose, this drug is now drawing attention…
Continue Reading
News Source: www.forbes.com
Leave a Reply